ScholarIQanswers from OpenAlex

Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease

PaperCitations, authors & open-access status

Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease have?

ScholarIQcitation count

Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease has 128 citations in the OpenAlex counts ScholarIQ stores.

When was Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease published?

ScholarIQyear

Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease has 2023 year in the ScholarIQ index.

What is the open-access status of Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease?

ScholarIQoa status

Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease has gold oa status in the ScholarIQ index.

What is the DOI of Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease?

ScholarIQdoi

The DOI for Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease is on the source record.

What is the PMID of Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease?

ScholarIQpmid

The PMID for Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease is on the source record.

What is the OpenAlex record for Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease?

ScholarIQopenalex

The OpenAlex for Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial